Market Size of Indonesia Diabetes Care Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 140.04 Million |
Market Size (2029) | USD 185.03 Million |
CAGR (2024 - 2029) | 5.73 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Indonesia Diabetes Care Devices Market Analysis
The Indonesia Diabetes Care Devices Market size is estimated at USD 140.04 million in 2024, and is expected to reach USD 185.03 million by 2029, growing at a CAGR of 5.73% during the forecast period (2024-2029).
Diabetes in Indonesia is considered a major health problem and has been a concern. Diabetes specialists have created recommendations for preventing and controlling diabetes to address the growing number of diabetics in Indonesia. Diabetes management is critical to preventing serious consequences such as neuropathy, nephropathy, retinopathy, microvascular disease, and cardiovascular disease.
Pharmacologic therapy such as oral medicines and insulin, as well as non-pharmacologic therapies such as lifestyle changes, are still considered modern approaches for diabetes management. These therapies are only possible through diabetes teaching programs that promote self-care management. Diabetes education programs are provided by healthcare providers in Indonesia. In Indonesia, the availability of certified diabetic educators is restricted, resulting in a scarcity of qualified health care professionals (HCPs) to educate persons with diabetes.
Furthermore, the increasing focus on self-care and self-monitoring among individuals with diabetes has also played a role in driving the market growth. Many individuals now prefer to monitor their blood glucose levels at home, rather than visiting healthcare facilities. This has led to a higher demand for blood glucose devices that can be used easily and effectively at home.
Overall, the rising number of diabetes cases in Indonesia has created a significant market opportunity for blood glucose devices. The combination of increased awareness, government initiatives, technological advancements, and changing patient preferences has fueled the growth of this market. As the diabetes epidemic continues to grow, the demand for blood glucose devices is expected to further increase, driving the market growth even further.